Related references
Note: Only part of the references are listed.Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism
Mathilde Chivet et al.
CELLS (2020)
Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy
Vittoria Lombardi et al.
NEUROLOGY (2019)
DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5
Naohide Kondo et al.
EMBO MOLECULAR MEDICINE (2019)
Prevalence of Carriers of Intermediate and Pathological Polyglutamine Disease-Associated Alleles Among Large Population-Based Cohorts
Sarah L. Gardiner et al.
JAMA NEUROLOGY (2019)
Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity
Uros Klickovic et al.
NEUROLOGY (2019)
Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy
Madoka Iida et al.
NATURE COMMUNICATIONS (2019)
Muscle contractility in spinobulbar muscular atrophy
Julia R. Dahlqvist et al.
SCIENTIFIC REPORTS (2019)
A SEVERE PHENOTYPE OF KENNEDY DISEASE ASSOCIATED WITH A VERY LARGE CAG REPEAT EXPANSION
Joao L. O. Madeira et al.
MUSCLE & NERVE (2018)
Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy
Nisha M. Badders et al.
NATURE MEDICINE (2018)
Biomarker-based analysis of preclinical progression in spinal and bulbar muscular atrophy
Yasuhiro Hijikata et al.
NEUROLOGY (2018)
Disease progression and outcome measures in spinobulbar muscular atrophy
Julia R. Dahlqvist et al.
ANNALS OF NEUROLOGY (2018)
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial
Christopher Grunseich et al.
LANCET NEUROLOGY (2018)
Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review
Giorgia Querin et al.
FRONTIERS IN NEUROLOGY (2018)
Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study
Atsushi Hashizume et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy
Robert D. Guber et al.
NEUROLOGY (2017)
Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes
Carmelo Milioto et al.
SCIENTIFIC REPORTS (2017)
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet
Anna Rocchi et al.
ACTA NEUROPATHOLOGICA (2016)
Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy
Jessica E. Poort et al.
HUMAN MOLECULAR GENETICS (2016)
Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy
Yasuhiro Hijikata et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy
Shinichiro Yamada et al.
PLoS One (2016)
Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy
Kentaro Sahashi et al.
HUMAN MOLECULAR GENETICS (2015)
A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study
Atsushi Hashizume et al.
NEUROMUSCULAR DISORDERS (2015)
Preventing the Androgen Receptor N/C Interaction Delays Disease Onset in a Mouse Model of SBMA
Lori Zboray et al.
CELL REPORTS (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy
Jason P. Chua et al.
HUMAN MOLECULAR GENETICS (2014)
Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy
Tomoo Mano et al.
NEUROLOGY (2014)
Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat
Christopher Grunseich et al.
NEUROMUSCULAR DISORDERS (2014)
Muscle Expression of Mutant Androgen Receptor Accounts for Systemic and Motor Neuron Disease Phenotypes in Spinal and Bulbar Muscular Atrophy
Constanza J. Cortes et al.
NEURON (2014)
Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy
Andrew P. Lieberman et al.
CELL REPORTS (2014)
Pilot trial of clenbuterol in spinal and bulbar muscular atrophy
Giorgia Querin et al.
NEUROLOGY (2013)
Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2
Yu Miyazaki et al.
NATURE MEDICINE (2012)
Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)
Masahisa Katsuno et al.
PROGRESS IN NEUROBIOLOGY (2012)
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial
Lindsay E. Fernandez-Rhodes et al.
LANCET NEUROLOGY (2011)
Macroautophagy Is Regulated by the UPR-Mediator CHOP and Accentuates the Phenotype of SBMA Mice
Zhigang Yu et al.
PLOS GENETICS (2011)
The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy
Keisuke Suzuki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial
Masahisa Katsuno et al.
LANCET NEUROLOGY (2010)
Native Functions of the Androgen Receptor Are Essential to Pathogenesis in a Drosophila Model of Spinobulbar Muscular Atrophy
Natalia B. Nedelsky et al.
NEURON (2010)
Phase 2 Trial of Leuprorelin in Patients with Spinal and Bulbar Muscular Atrophy
Haruhiko Banno et al.
ANNALS OF NEUROLOGY (2009)
Clinical features of spinal and bulbar muscular atrophy
Lindsay E. Rhodes et al.
BRAIN (2009)
Mitochondrial abnormalities in spinal and bulbar muscular atrophy
Srikanth Ranganathan et al.
HUMAN MOLECULAR GENETICS (2009)
STANDARD AND MODIFIED STATISTICAL MUNE EVALUATIONS IN SPINAL-BULBAR MUSCULAR ATROPHY
Tanya J. Lehky et al.
MUSCLE & NERVE (2009)
Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy
Isabella Palazzolo et al.
NEURON (2009)
Spinal and bulbar muscular atrophy:: Skeletal muscle pathology in male patients and heterozygous females
Gianni Soraru et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor
Zhiming Yang et al.
NATURE MEDICINE (2007)
Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients
Naoki Atsuta et al.
BRAIN (2006)
Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease
M Katsuno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
M Waza et al.
NATURE MEDICINE (2005)
Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients
H Adachi et al.
BRAIN (2005)
Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy
M Katsuno et al.
NEURON (2002)
Share Paper
